ReiThera Srl is a biotech company dedicated to the technology development, GMP manufacturing and clinical translation of genetic vaccines and medicinal products for advanced therapies. ReiThera’s management and scientific teams developed a highly innovative technological platform based on simian adenoviral vectors for vaccine and advanced therapy applications. ReiThera is actively working on scalable processes applicable to different viral vectors: AAV, LV, MVA, HSV.

ReiThera is led by an experienced management team that worked together for many years in previous successful enterprises with a long-standing expertise in scalable processes for viral vector manufacturing, supported by a cGMP facility inclusive of filling suite and quality control laboratories.